Journal of Clinical Epidemiology
Volume 63, Issue 4 , Pages 428-434 , April 2010

Older Australians' medication use: self-report by phone showed good agreement and accuracy compared with home visit

  • Sabrina Pit

      Affiliations

    • Northern Rivers University Department of Rural Health, School of Public Health, University of Sydney, Lismore, New South Wales, Australia
    • Corresponding Author InformationCorresponding author. Northern Rivers University Department of Rural Health, School of Public Health, University of Sydney, 61 Uralba Street, PO Box 3074, Lismore NSW 2480, Australia. Tel.: +61-2-6620-7374; fax: +61-2-6620-7270.
    • ,
  • Julie Byles

      Affiliations

    • Research Centre for Gender, Health and Ageing, Faculty of Health, The University of Newcastle, Newcastle, New South Wales, Australia

,Accepted 14 July 2009.

References 

  1. Stewart M. The validity of an interview to assess a patient's drug taking. Am J Prev Med. 1987;3:95–100
  2. Klungel OH, de Boer A, Paes AH, Herings RM, Seidell JC, Bakker A. Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in The Netherlands. Pharm World Sci. 1999;21:217–220
  3. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance?. Hypertension. 1980;2:757–764
  4. Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37:846–857
  5. Pit S, Byles J, Cockburn J. Telephone self-report of drug use in older people. Drugs Aging. 2008;25:71–80
  6. Metlay JP, Hardy C, Strom BL. Agreement between patient self-report and a Veterans Affairs national pharmacy database for identifying recent exposures to antibiotics. Pharmacoepidemiol Drug Saf. 2003;12:9–15
  7. Wang PS, Benner JS, Glynn RJ, Winkelmayer WC, Mogun H, Avorn J. How well do patients report noncompliance with antihypertensive medications? A comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf. 2004;13:11–19
  8. Pit S, Byles J, Henry D, Holt L, Hansen V, Bowman D. A Quality Use of Medicines Program for general practitioners and older people: a cluster randomised controlled trial. Med J Aust. 2007;187:23–30
  9. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical therapeutic chemical (ATC) classification index with defined daily doses (DDDs). Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2001;
  10. Byrt T, Bishop J, Carlin JB. Bias, prevalence and kappa. J Clin Epidemiol. 1993;46:423–429
  11. Hripcsak G, Heitjan DF. Measuring agreement in medical informatics reliability studies. J Biomed Inform. 2002;35:99–110
  12. Kehoe R, Wu SY, Leske MC, Chylack LT. Comparing self-reported and physician-reported medical history. Am J Epidemiol. 1994;139:813–818
  13. Lau HS, de Boer A, Beuning KS, Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol. 1997;50:619–625
  14. Smith NL, Psaty BM, Heckbert SR, Tracy RP, Cornell ES. The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly. J Clin Epidemiol. 1999;52:143–146
  15. Hancock L. Drug use in the Australian community: prevalence sociodemographic characteristics of users, and context of use. [Doctoral dissertation] Newcastle NSW: University of Newcastle; 1991;
  16. Johnson RE, Vollmer WM. Comparing sources of drug data about the elderly. J Am Geriatr Soc. 1991;39:1079–1084
  17. King MA, Purdie DM, Roberts MS. Matching prescription claims with medication data for nursing home residents: implications for prescriber feedback, drug utilisation studies and selection of prescription claims database. J Clin Epidemiol. 2001;54:202–209
  18. Sjahid SI, van der Linden PD, Stricker BH. Agreement between the pharmacy medication history and patient interview for cardiovascular drugs: the Rotterdam elderly study. Br J Clin Pharmacol. 1998;45:591–595

 Conflict of interests: none.

 Declaration of sources of funding: financial sponsors played no role in the design execution, analysis and interpretation of data.

PII: S0895-4356(09)00208-X

doi: 10.1016/j.jclinepi.2009.07.008

Journal of Clinical Epidemiology
Volume 63, Issue 4 , Pages 428-434 , April 2010

Article Tools

* Image Usage & Resolution